Minority youth represent a unique population for public health interventions given the social,
economic, and cultural barriers they often face in accessing health services. Interventions to …

Objectives: We systematically reviewed the literature on the impact of public education on
HPV vaccine uptake. Design: PubMed was searched to identify studies published between …

Human papillomavirus (HPV) is the most common sexually transmitted infection in the US.
HPV vaccine is a viable source of prevention against high-risk strains that are likely to cause …

Background Human papillomavirus (HPV) is associated with poor health outcomes,
including cervical cancer. Racial/ethnic minority populations experience poor health …

In 2009, a quadrivalent HPV vaccine was approved and “permissively” recommended for US
males aged 9 to 26 y to protect against genital warts. The purpose of this study was to …

Vaccination is a safe and effective way to prevent Human Papillomavirus (HPV) infection
and related cancers; however, HPV vaccine uptake remains low in the US. After the 2011 …

Purpose: To examine correlates of HPV vaccination uptake in a nationally representative
sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified …

The human papillomavirus (HPV) causes many anogenital and oral cancers affecting young
adults in the United States. Vaccination during adolescence can prevent HPV‐associated …

Human papillomavirus (HPV) infection, the most common sexually transmitted disease in the
US, is a preventable cause of cancer. HPV vaccination has the potential to prevent 90% of …

Abstract In the United States (US), an estimated 35,900 human papillomavirus (HPV)-related
cancers are diagnosed annually. HPV vaccines are projected to eliminate∼ 90% of these …